This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 4 CIPO patents and 2 EPO patents. Top assignee: Ascendis Pharma Growth Disorders A/s. Active years: 2020-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2022
Title: The Innovative Journey of Caroline Elisabeth Rasmussen
Introduction
Caroline Elisabeth Rasmussen is a notable inventor based in Virum, Denmark, recognized for her significant contributions to pharmaceutical innovations. With a total of five patents to her name, Caroline has been at the forefront of developing advanced therapeutic solutions.
Latest Patents
Caroline's latest patents reflect her expertise in the field of controlled-release pharmaceuticals. One of her notable inventions is centered around "CNP prodrugs with carrier attachment at the ring moiety." This invention pertains to CNP prodrugs where the carrier is covalently and reversibly connected to the ring moiety, alongside pharmaceutical compositions that include these prodrugs. This innovation plays a critical role in treating diseases associated with CNP prodrugs.
Another of her remarkable patents is "Controlled-release CNP agonists with low initial NPR-B activity." This invention details a controlled-release CNP agonist that is designed to release the CNP agonist with a half-life of at least six hours under physiological conditions. Her work in this patent offers pharmaceutical compositions that significantly enhance the efficacy of treatment methods.
Career Highlights
Caroline has played a pivotal role in her organization, Ascendis Pharma Growth Disorders A/S, driving innovative research and development. Her dedication to advancing therapeutic options showcases her commitment to improving patient care through scientific exploration.
Collaborations
Throughout her career, Caroline has collaborated with esteemed colleagues, including Harald Rau and Ulrich Hersel. These partnerships underline the importance of teamwork in fostering ground-breaking research and developing impactful therapies.
Conclusion
Caroline Elisabeth Rasmussen embodies the spirit of innovation in her field. With her extensive patent portfolio and collaborative efforts, she continues to make significant strides in pharmaceutical research, contributing to advancements that could transform treatment options for patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile